HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.
EatStreet, Inc. is an online and mobile food ordering service that connects diners with local restaurants across the United States. Founded in 2009 and headquartered in Madison, Wisconsin, the platform offers a comprehensive listing of partnered restaurants, allowing users to easily order delivery or takeout from their favorite eateries. Targeting college students and young professionals, EatStreet provides a simple and cost-effective way to access a variety of food options. For restaurant owners, the service acts as a centralized hub for online ordering and marketing, helping to increase visibility and sales. By facilitating fast and convenient food ordering, EatStreet enhances the dining experience for customers while supporting local businesses.
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.
Rentable is an internet company that specializes in providing a web-based platform that allows its users to conduct an online internet apartment search. The company was established in 2011 and is based in Madison, Wisconsin.
Madison Vaccines, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing therapeutic plasmid DNA vaccines for prostate cancer and its associated bone metastases. Founded by Douglas McNeel, M.D., Ph.D., and Richard Lesniewski, Ph.D., the company is working on two primary vaccines: pTVG-HP and pTVG-AR. The lead vaccine, pTVG-HP, is administered via intradermal injection and targets prostatic acid phosphatase (PAP), with ongoing Phase 2 clinical trials for men at high risk of developing bone metastases following prostate cancer treatment. Initial trials have shown promising biological and biochemical activity. The second vaccine, pTVG-AR, aims to target the androgen receptor, a key driver of prostate cancer growth, and is expected to enter clinical trials soon. Additionally, Madison Vaccines is developing a companion diagnostic test based on a novel blood signature identified by the McNeel lab, which could help predict patient responses to these vaccines.
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.
Datica is a cloud-based healthcare platform established in 2013 and headquartered in Minneapolis, Minnesota. The company specializes in facilitating clinical data exchange for highly regulated industries, particularly in healthcare. Datica's platform enables developers to implement cloud-based user management, secure messaging, and data storage without the complexities of server configuration. This functionality supports the integration of electronic health records (EHR) and ensures compliance with industry regulations. Datica serves a diverse clientele, ranging from mid-to-late-stage startups to Fortune 100 companies, helping them manage sensitive information effectively while streamlining their operations and enhancing data interoperability.
Neurovance, Inc. is a clinical-stage neuroscience company headquartered in Cambridge, Massachusetts, focused on developing therapies for attention deficit hyperactivity disorder (ADHD) in both adults and children. The company's primary product, centanafadine, is a triple reuptake inhibitor that specifically modulates the activity of norepinephrine, dopamine, and serotonin to address symptoms such as lack of focus, inattention, and disorganization associated with ADHD. Founded in 2009 and incorporated in 2011, Neurovance has received venture capital funding from several investors, including the Novartis Venture Fund and the State of Wisconsin Investment Board. As of March 2017, Neurovance operates as a subsidiary of Otsuka America, Inc.
EatStreet, Inc. is an online and mobile food ordering service that connects diners with local restaurants across the United States. Founded in 2009 and headquartered in Madison, Wisconsin, the platform offers a comprehensive listing of partnered restaurants, allowing users to easily order delivery or takeout from their favorite eateries. Targeting college students and young professionals, EatStreet provides a simple and cost-effective way to access a variety of food options. For restaurant owners, the service acts as a centralized hub for online ordering and marketing, helping to increase visibility and sales. By facilitating fast and convenient food ordering, EatStreet enhances the dining experience for customers while supporting local businesses.
Madison Vaccines, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing therapeutic plasmid DNA vaccines for prostate cancer and its associated bone metastases. Founded by Douglas McNeel, M.D., Ph.D., and Richard Lesniewski, Ph.D., the company is working on two primary vaccines: pTVG-HP and pTVG-AR. The lead vaccine, pTVG-HP, is administered via intradermal injection and targets prostatic acid phosphatase (PAP), with ongoing Phase 2 clinical trials for men at high risk of developing bone metastases following prostate cancer treatment. Initial trials have shown promising biological and biochemical activity. The second vaccine, pTVG-AR, aims to target the androgen receptor, a key driver of prostate cancer growth, and is expected to enter clinical trials soon. Additionally, Madison Vaccines is developing a companion diagnostic test based on a novel blood signature identified by the McNeel lab, which could help predict patient responses to these vaccines.
Datica is a cloud-based healthcare platform established in 2013 and headquartered in Minneapolis, Minnesota. The company specializes in facilitating clinical data exchange for highly regulated industries, particularly in healthcare. Datica's platform enables developers to implement cloud-based user management, secure messaging, and data storage without the complexities of server configuration. This functionality supports the integration of electronic health records (EHR) and ensures compliance with industry regulations. Datica serves a diverse clientele, ranging from mid-to-late-stage startups to Fortune 100 companies, helping them manage sensitive information effectively while streamlining their operations and enhancing data interoperability.
Montage Talent, Inc. specializes in providing live and on-demand voice and video interviewing solutions tailored for large enterprises, healthcare sectors, and staffing and recruitment process outsourcing firms. Established in 2007 and based in Delafield, Wisconsin, the company was previously known as Expressume, Inc. and adopted its current name in 2001. Montage serves a diverse clientele, including numerous Fortune 500 companies, by delivering a modern hiring experience that combines advanced technology with personalized service. As a pioneer in purpose-built video interviewing, Montage's proprietary platform is designed for reliability, scalability, compliance, and security, ensuring it meets enterprise demands. The company emphasizes innovation driven by market needs and data, aiming to enhance the efficiency and predictability of talent acquisition. Additionally, Montage is dedicated to fostering long-term client relationships and providing exceptional support at every stage of the hiring process.
Neurovance, Inc. is a clinical-stage neuroscience company headquartered in Cambridge, Massachusetts, focused on developing therapies for attention deficit hyperactivity disorder (ADHD) in both adults and children. The company's primary product, centanafadine, is a triple reuptake inhibitor that specifically modulates the activity of norepinephrine, dopamine, and serotonin to address symptoms such as lack of focus, inattention, and disorganization associated with ADHD. Founded in 2009 and incorporated in 2011, Neurovance has received venture capital funding from several investors, including the Novartis Venture Fund and the State of Wisconsin Investment Board. As of March 2017, Neurovance operates as a subsidiary of Otsuka America, Inc.
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.
Mithridion, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on discovering and developing small molecule drugs to address unmet medical needs, particularly in the area of central nervous system disorders. The company targets serious chronic neurodegenerative diseases, including orphan diseases and schizophrenia. Its drug portfolio includes MCD-386CR, aimed at treating cognitive impairments associated with Progressive Supranuclear Palsy and other neurodegenerative conditions; MCD-386/glycopyrrolate, designed as a preventative therapy for genetically-defined presymptomatic mutation carriers of autosomal dominant Alzheimer’s disease; MI-08-016/035, which are candidates for common neurodegenerative diseases; and MI-10-022, targeting significant unmet needs in schizophrenia. Founded in 2004, Mithridion aims to provide innovative therapeutic solutions for complex neurological conditions.
Pinstripe is a top RPO provider with global reach and high customer satisfaction as recognized by HRO Today’s Baker’s Dozen. They serve world-class organizations in financial services, healthcare, pharmaceuticals, technology, advanced manufacturing, biotech, telecommunications and energy.
OpGen, Inc. is a precision medicine company based in Gaithersburg, Maryland, that specializes in developing molecular diagnostics and informatics aimed at combating infectious diseases. The company offers a range of products, including the Acuitas AMR Gene Panel, which detects bacterial nucleic acids and antimicrobial resistance markers, and QuickFISH and PNA FISH tests for identifying pathogens in blood cultures. Additionally, OpGen provides the Acuitas Lighthouse informatics system, a cloud-based platform that integrates clinical lab results with patient data to help manage multidrug-resistant organisms in healthcare settings. Through its strategic collaboration with the New York State Department of Health, OpGen is working on solutions to detect and manage antimicrobial-resistant infections in healthcare facilities. The company's innovative technologies are utilized by academic, government, and research institutions globally for applications such as strain typing and genome assembly. OpGen aims to enhance patient care and outcomes while addressing the growing challenge of antibiotic resistance.
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal storage diseases.
Roche NimbleGen specializes in providing a range of products and services for the life science research market, particularly in DNA sequencing and microarray technology. The company offers the SeqCap EZ system, which allows for exome enrichment in a single test tube, along with various design options and reagents to facilitate workflow. Additionally, Roche NimbleGen has developed the SeqCap Epi system for DNA methylation assessment at single-base resolution, and it supplies preparation and adapter kits for library construction. Their proprietary Maskless Array Synthesis technology enables the creation of custom high-density DNA arrays, enhancing the quality and data yield of sequencing efforts. The company also provides a suite of DNA microarray products for applications such as comparative genomic hybridization and gene expression analysis, alongside technical support services. Founded in 1999 and based in Madison, Wisconsin, Roche NimbleGen operates as a subsidiary of Roche Holding AG.
Roche NimbleGen specializes in providing a range of products and services for the life science research market, particularly in DNA sequencing and microarray technology. The company offers the SeqCap EZ system, which allows for exome enrichment in a single test tube, along with various design options and reagents to facilitate workflow. Additionally, Roche NimbleGen has developed the SeqCap Epi system for DNA methylation assessment at single-base resolution, and it supplies preparation and adapter kits for library construction. Their proprietary Maskless Array Synthesis technology enables the creation of custom high-density DNA arrays, enhancing the quality and data yield of sequencing efforts. The company also provides a suite of DNA microarray products for applications such as comparative genomic hybridization and gene expression analysis, alongside technical support services. Founded in 1999 and based in Madison, Wisconsin, Roche NimbleGen operates as a subsidiary of Roche Holding AG.
Cardiac Pathways Corp
Venture Round in 2000
Cardiac Pathways Corp manufactures minimally-invasive systems used by electrophysiologists to diagnose and treat cardiac tachyarrhythmia (abnormally rapid heart rhythms), which if untreated can cause palpitations, fainting, and sudden cardiac arrest. Cardiac Pathways' products consist principally of systems for performing ablation treatment (a nonsurgical, minimally-invasive technique for neutralizing heart tissue responsible for starting or maintaining a tachyarrhythmia) and for diagnostic mapping (locating the source of the tachyarrhythmia within the heart). Cardiac Pathways was issued a U.S. patent related to its Real-time Position Management Tracking System. Founded in 1991, Cardiac Pathways is based in Sunnyvale, California. As of August 6, 2001, it was acquired by Boston Scientific Corporation.